Mark Leuchtenberger
Director, EPIX Pharmaceuticals, Inc.
Companies
- NeuroSense Therapeutics Ltd.Board member Mar 18, 2026 to now1
- Chiasma (United States)Chief executive officer Feb 12, 2016 to Feb 12, 20162
- Chiasma (United States)President Feb 12, 2016 to Feb 12, 20162
- Chiasma (United States)Board member Jul 15, 2015 to Feb 12, 20163
- Chiasma (United States)Officer Jul 15, 2015 to Jul 15, 20153
- Targanta Therapeutics CorporationBoard member Oct 10, 2007 to Feb 8, 20084
- Targanta Therapeutics CorporationChief executive officer Oct 10, 2007 to Feb 8, 20084
- Targanta Therapeutics CorporationPresident Oct 10, 2007 to Feb 8, 20084
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- NeuroSense Therapeutics Ltd. NRSN122,951 shares5$389.8K at $3.17Mar 18, 2026
As of each latest filing. The line shows shares held over time.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5